OPKO Health, Inc. 13D and 13G filings for Cocrystal Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-11-19 4:01 pm Purchase |
2020-11-13 | 13D | Cocrystal Pharma, Inc. COCP |
Opko Health Inc. OPK |
307,921 5.400% |
781 (+0.25%) |
Filing |